Table 1. Characteristics of patients with cutaneous and mucosal leishmaniasis, Germanya.
| No. | Exposure | Status | Sex | Age (y) | Leishmania species | Treatment | Outcome |
|---|---|---|---|---|---|---|---|
| Europe |
|
||||||
| 1 |
France |
Tourist |
F |
64 |
L. donovani complex |
No treatment |
No cure |
| 2 |
Italy |
Tourist |
F |
24 |
L. donovani complex |
Liposomal amphotericin B |
Improved |
| 3 |
Malta |
Tourist |
M |
22 |
L. donovani complex |
Perilesional pentavalent antimonials |
Cured |
| 4 |
Malta |
Tourist |
M |
39 |
L. donovani complex |
Perilesional pentavalent antimonials |
Cured |
| 5 |
Malta |
Tourist |
F |
57 |
n.d. |
Perilesional pentavalent antimonials |
Cured |
| 6 |
Malta |
Tourist |
M |
62 |
n.d. |
Perilesional pentavalent antimonials |
Cured |
| 7 |
Spain (Majorca) |
Tourist |
F |
5 |
n.d. |
Pentamidine isethionate |
Cured |
| 8 |
Spain (Majorca) |
Tourist |
M |
13 |
L. donovani complex |
Perilesional pentavalent antimonials |
Cured |
| 9 |
Spain |
Tourist |
F |
31 |
L. donovani complex |
No treatment |
Unknown |
| 10 |
Spain |
Tourist |
M |
33 |
L. donovani complex |
Antibiotic |
Cured |
| Americas |
|
||||||
| 11 |
Belize |
Tourist |
M |
36 |
L. braziliensis complex |
Liposomal amphotericin B |
Unknown |
| 12 |
Belize |
Tourist |
F |
32 |
n.d. |
IFN-gamma |
Cured |
| 13 |
Bolivia |
Tourist |
M |
35 |
L. braziliensis complex |
Liposomal amphotericin B |
Unknown |
| 14 |
Brazil |
Tourist |
M |
25 |
n.d. |
Systemic pentavalent antimonials |
Cured |
| 15 |
Brazil |
Tourist |
M |
39 |
L. braziliensis complex |
Liposomal amphotericin B |
Unknown |
| 16 |
Brazil |
Tourist |
M |
33 |
L. braziliensis complex |
Liposomal amphotericin B |
Cured |
| 17 |
Ecuador |
Tourist |
F |
29 |
L. braziliensis complex |
Liposomal amphotericin B |
Cured |
| 18 |
Ecuador |
Tourist |
M |
36 |
n.d. |
Liposomal amphotericin B |
Cured |
| 19 |
French Guyana |
Work stay |
M |
28 |
L. braziliensis complex |
Liposomal amphotericin B |
Cured |
| 20 |
French Guyana |
Work stay |
M |
22 |
L. braziliensis complex |
Liposomal amphotericin B |
Cured |
| 21 |
Guatemala |
Tourist |
M |
31 |
L. mexicana
|
Ketokonazole |
Cured |
| 22 |
Peru |
Work stay |
F |
25 |
L. braziliensis complex |
Liposomal amphotericin B |
Cured |
| 23 |
Peru |
Tourist |
F |
33 |
L. braziliensis complex |
Liposomal amphotericin B |
Cured |
| 24 |
Peru |
Tourist |
M |
35 |
L. braziliensis complex |
Liposomal amphotericin B |
Cured |
| Asia |
|
||||||
| 25 |
Afghanistan |
Immigrant |
M |
21 |
L. tropica
|
Aminosidine ointment |
No cure |
| 26 |
Afghanistan |
Tourist |
F |
12 |
n.d. |
Aminosidine ointment |
Cured |
| 27 |
United Arab Emirates |
Tourist |
F |
44 |
n.d. |
Perilesional pentavalent antimonials |
Cured |
| 28 |
Syria |
Tourist |
M |
5 |
n.d. |
Perilesional pentavalent antimonials |
Unknown |
| 29 |
Syria |
Tourist |
F |
3 |
n.d. |
Perilesional pentavalent antimonials |
Unknown |
| 30 |
Turkey |
Tourist |
F |
33 |
n.d. |
Antibiotic |
Cured |
| 31 |
Turkey |
Tourist |
M |
37 |
L. donovani complex |
Liposomal amphotericin B |
Improved |
| Africa |
|
||||||
| 32 |
Egypt |
Tourist |
M |
25 |
L. tropica
|
Aminosidine ointment |
No cure |
| 33 |
Egypt |
Tourist |
F |
27 |
L. tropica
|
Aminosidine ointment |
Cured |
| 34 |
Kenya |
Tourist |
M |
50 |
n.d. |
Perilesional pentavalent antimonials |
Cured |
| 35 | Lybia | Work stay | M | 34 | n.d. | Aminosidine ointment | Cured |
an.d., not done; IFN, interferon.